MedTrace Logo

Use of Drug-Coated Balloon to Improve Recanalization of a Coronary Chronic Total Occlusion After Failed Angioplasty

NCT05158686 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2022-04-22

No results posted yet for this study

Summary

Observational retrospective registry to compare effectiveness of paclitaxel-coated vs. non coated balloon angioplasty proximal to a Chronic Total Occlussion (CTO) after failed revascularization. Primary objective is to determine success rate after repeated percutaneous coronary intervention of a CTO 3 to 6 months after paclitaxel-coated balloon angioplasty proximal to the persistent lesion.

Conditions

  • Chronic Total Occlusion

Interventions

DEVICE

Paclitaxel-coated Balloon dilation angioplasty

Paclitaxel-coated ballon dilation angioplasty proximal to CTO lesion after failed percutaneous recanalization

DEVICE

Non-coated Balloon dilation angioplasty

Non-coated ballon dilation angioplasty proximal to CTO lesion after failed percutaneous recanalization

Sponsors & Collaborators

  • Ignacio J. Amat Santos

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2020-10-01
Completion
2021-12-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05158686 on ClinicalTrials.gov